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Abstract. An abnormal dexamethasone suppression test (DST) result, a sensitive 
and specific marker for endogenous depression, was found to be associated with an 
antidepressant response to sleep deprivation in patients who met DSM-/[/criteria 
for Major Depressive Episode regardless of whether they met criteria for melan- 
cholia or psychotic subtypes of this disorder. These findings support previous 
reports of an association between an abnormal DST result and antidepressant 
effects of sleep deprivation in depressed patients. Our results extend the positive 
association between an abnormal DST result and the antidepressant response to 
sleep deprivation to include depressed patients who are clinically nonmelancholic 
during their current episode but who have an abnormal DST result. 
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Total night sleep deprivation produces a definite but usually transient antidepressant 
effect (SDAE = sleep deprivation antidepressant effect) in 40 to 75% of depressed 
patients studied (King, 1977). This effect is most often, though not always, seen in 
patients with endogenous depression (Pflug, 1976). Thus diagnostic subtype does not 
totally account for the variability of response to sleep deprivation among depressed 
patients, 
Nasrallah and Coryell (1982) have reported that an abnormal dexamethasone 
suppression test (DST) result is associated with the SDAE in patients who meet 
DSM-III (American Psychiatric Association, 1980) criteria for major depression. An 
abnormal DST result has been shown to be a sensitive and highly specific marker of 
endogenous depression (melancholia) (Carroll et al., 198 1). Therefore, a positive asso- 
ciation between an abnormal DST and SDAE is consistent with data which support 
an association between a clinical diagnosis of endogenous depression and SDAE. 
Because some patients with endogenous depression do not exhibit SDAE while some 
patients with nonendogenous depression do, it would be of interest to determine 
whether an abnormal DST distinguishes sleep deprivation responsive from nonres- 
ponsive patients with nonendogenous as well as endogenous depression. 
In a study of the effect of 1 night of sleep deprivation in eight patients with 
endogenous depression, Albala et al. (1981) reported that an abnormal DST result did 
Doug King, M.D., is Assistant Professor, and Robert Gardner, Ph.D., is Research Associate, Clinical 
Studies Unit, Department of Psychiatry, University of Michigan, Ann Arbor, Ml. Suzanne Dowdy, M.D., 
Rob Jack, M.D., and Palmer Edwards, M.D., are Residents in Psychiatry, Vanderbilt University, Nash- 
ville, TN. At the time this research was carried out, Dr. King was Assistant Professor of Psychiatry at 
Vanderbilt University. (Reprint requests to Dr. D. King, Clinical Studies Unit, Dept. of Psychiatry, 
University of Michigan, Ann Arbor, MI 48109, USA.) 
0 I65- I78 I ; 82 :OOOO-OOOO/ $02.75 @ Elsevier Biomedical Press 
94 
not distinguish sleep deprivation responsive from nonresponsive patients. Seventy- 
five percent of their sample exhibited SDAE. These results suggest that in a patient 
population with a high likelihood of exhibiting SDAE (endogenous depression) an 
abnormal DST result adds no predictive information with respect to SDAE. 
In order to address further the issue of whether DST results predict sleep depriva- 
tion effects independently of clinical diagnosis, we retrospectively tested the following 
hypotheses: (1) in patients with major depression (not subtyped in terms of presence or 
absence of melancholia) an abnormal DST is positively associated with SDAE (i.e., 
replicating the findings of Nasrallah and Coryell, 1982); (2) in patients with major 
depression without melancholia an abnormal DST result is positively associated with 
SDAE; (3) in patients categorized by DST result and clinical diagnosis, the following 
rank order would be found with respect to SDAE: (melancholia and abnormal DST) 
> (either melancholia or abnormal DST) > (neither melancholia nor abnormal DST). 
Methods 
Subjects. Charts for all patients admitted during the preceding 12 months were screened (by 
S.D.) and a sample consisting of 10 depressed inpatients who met the following criteria was 
obtained: ( I) DSM-III criteria for major depressive episode; diagnoses were derived by consen- 
sus of two raters (D.K. and R.J.) who independently diagnosed each patient using the following 
data: (a) psychiatric history and mental status examination obtained on admission (semistruc- 
tured interview); (b) discharge summary; (c) all available records from previous psychiatric 
admissions. (2) DST performed within the first week of hospitalization (did not meet any of the 
medical exclusion criteria of Carroll et al., 198 1, for the DST). (3) One night of sleep deprivation 
(36 to 42 hours without sleep) which occurred while the patient was moderately or severely 
depressed (global clinical impression) but after completion of the DST. Two patients were 
sleep-deprived within a week of having had the DST. All other patients were sleep-deprived at 
least a week after the DST. Demographic features of the sample are given in Table I. 
Diagnostic Criteria. All patients met DSM-IfIcriteria for major depression for their current 
episode. In this study patients who met the criteria for melancholia or psychotic depression are 
referred to as melancholic, though the specific subclassification is indicated in Table I. Patients 
were also diagnosed as bipolar or unipolar based on historical data. 
Dexamethasone Suppression Test. Dexamethasone, I. 125 mg, p.o., was administered at 
2300 h and a blood sample for serum cortisol was drawn at 1600 h on the following day. An 
abnormal result was considered to occur when serum cortisol was > 5 pg/dl. Serum cortisol 
levels were determined by Gamma Coat [I*511 Cortisol Radioimmunoassay Kit.1 
Sleep Deprivation. In our sample there were three types of sleep deprivation: (1) therapeutic 
(n = 4); (2) sleep deprivation electroencephalogram (EEG) (n = 4); (3) self-imposed (n = 2) 
(Table 1). “Therapeutic” sleep deprivation was given for potential antidepressant benefit. 
Patients were informed of potential therapeutic outcome before the deprivation procedure. 
Sleep deprivation EEG studies were conducted to rule out seizure disorder. Patients with 
“self-imposed” sleep deprivation were not requested to stay awake for therapeutic effects or an 
EEG study but remained awake due to “total insomnia.” In all cases, except when deprived for 
sleep EEG, patients remained awake for 36 to 42 hours. Patients deprived of sleep for EEG 
study slept up to 30 minutes, between 8 and 10 a.m., during the EEG. Patients who had sleep 
I. Radioimmunoassay Kit available from Clinical Assays, Division of Travenol Laboratories, Inc., Cam- 
bridge. MA 02 139. 
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deprivation EEGs were requested to remain awake until their regular bedtime after their EEG 
study in order to “maintain their sleep-wake cycle.” During the deprivation night patients stayed 
in the ward “day room” in full view of the nurses station. They played cards, read, walked, and 
talked with ward staff. Patients were allowed to shower if necessary to remain awake. In all cases 
patients were moderately to severely depressed (global clinical assessment) when sleep- 
deprived. At the time of deprivation six patients were taking tricyclic antidepressants, two were 
taking monoamine oxidase inhibitors, one was taking a neuroleptic, and one was on no 
medication (Table 1). Medications were not withheld for sleep deprivation. 
Table 1. Diagnosis, demographic data, medication, type of sleep deprivation 
and response to sleep deprivation for 10 inpatients meeting DSM-//I criteria 
for maior deDreSSiVe eDisode 
Subtype of 
maior deoression Age 
Type of 
DST sleep depri- Rated 
Sex Medication result vation resoonse 
Bipolar (psychotic) 50 M TCA NS EEG 6 
Unipolar 72 F TCA NS Therapy 3.5 
Unipolar (melancholia) 61 F TCA NS EEG 4 
Unipolar 48 F MAOI NS Therapy 5.25 
Bipolar 38 M none NS Self-imposed 4 
Unipolar 30 M TCA S Therapy 3 
Unipolar 58 F TCA S EEG 3.75 
Bipolar (psychotic) 28 M Neuroleptic S EEG 4 
Unipolar 22 M MAOI S Self-imposed 1.5 
Unipolar 35 M TCA S Therapy 1.75 
Abbreviations: M = male; F = female; TCA = tricyclic; MAOI = monoamine oxidase inhibitor; NS = nonsuppres- 
sion or sbnormal result; S = suppression or normal result. 
See Table 2 for response rating scale. 
Sleep Deprivation Response Ratings. Composite descriptions of each patient’s mental 
status and behavior for the day before and the day after sleep deprivation were obtained by 
extracting all descriptive material from nursing notes and progress notes. Progress notes 
(recorded daily by a psychiatric resident) routinely contained assessments of“target symptoms” 
(i.e., symptoms relevant to tracking an individual’s progress) such as mood, vegetative symp- 
toms, and psychomotor status, as well as descriptions of ward behavior and social interaction. 
The composite descriptions were coded (contained no information regarding identity of the 
patient or DST results) and were independently rated by four raters (three had no contact with 
patients) using the 6-point scale in Table 2. The mean of the four ratings for each patient is given 
in Table 1. These ratings reflect postdeprivation status for the day immediately following sleep 
deprivation relative to predeprivation status. 
Results 
Diagnosis, demographic data, medication, type of sleep deprivation and rated 
response to sleep deprivation for our 10 patients are given in Table 1. The mean age for 
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our sample was 44.2 years. Mean ages for DST nonsuppressor and suppressor 
subgroups, respectively, were 53.8 years and 34.6 years. The overall male:female ratio 
was 3:2. DST nonsuppressors had a 2:3 and suppressors a 4: 1 male:female ratio. 
Table 2. Sleeo deorivation resoonse ratina scale 
1. Worsening Definite evidence, subjective or objective, of exacerbation of 
depression 
2. No change No subjective or objective evidence of improvement or worsen- 
ing 
3. Minimal improvement Subjective report of some improvement in mood or energy, etc., 
but objective evidence is lacking or minimal 
4. Moderate improvement Subjective and objective evidence of improvement in more than 
one dimension, but patient cannot unequivocally be rated as 
as euthymic 
5. Marked improvement Subjective and objective evidence that the patient’s mood has 
normalized. No evidence of residual symptoms of depression 
6. Euphoria Definite euphoria; some behavioral evidence of activation (e.g.. 
increased rate of speech, or increased psychomotor activity); 
no residual symptoms of depression 
Sleep deprivation response ratings were converted to ranked scores and Mann- 
Whitney U tests were run on each comparison in Table 3 (Blalock, 1979). Hypothesis 1 
predicted that DST nonsuppression would be positively associated with SDAE. Based 
on a review of the literature, it was predicted that age, sex, and type of sleep 
deprivation would be unrelated (King, 1977). 
Table 3. Subgrouping for 10 depressed inpatients (DST result, sex, age, type 
of sleep deprivation) with median rated response to sleep deprivation, DST 
results (number and percentage) and Mann-Whitney U test results for each 
comparison 
Median rated 
n response % NS P 
Nonsuppressors 5 4 100% < 0.032 
vs. suppressors 5 3 0% 
Males vs. 6 3.5 33% < 0.613 
females 4 4.6 75% 
Age 45 or younger 5 3.5 20% < 0.153 
vs. age 45 or older 5 3.9 60% 
Therapy vs. 4 3.3 50% c 0.483 
others 6 3.5 50% 
1. Percent of DST nonsuppressors. 
2. One-tailed comparison. 
3. Two-talled comparison. 
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DST nonsuppressors were rated as having a significantly greater SDAE than DST 
suppressors @ < 0.028, one-tailed). Types of sleep deprivation (therapeuticvs. other), 
age, and sex did not differentiate responders from nonresponders. 
For subgroupings based on age and sex, the highest percentage of DST nonsuppres- 
sors was found in the subcategory associated with higher median sleep deprivation 
response ratings (Table 3). Thus females had a higher median response rating (i.e., 
better response) than males and also had a higher percentage of DST nonsuppressors 
(75%) than males (33%). The same relationship held for age. Patients who received 
sleep deprivation as therapy did not differ from patients sleep-deprived for other 
reasons (EEG, insomnia) in terms of percentage of DST nonsuppressors (50% vs. 
50%) and these subgroups had the most similar median response ratings (3.3 vs. 3.5). 
Our second hypothesis predicted that an abnormal DST result would be associated 
with SDAE in major depression patients without melancholia. Seven of our patients 
did not meet criteria for melancholia and three of these had an abnormal DST. A 
Mann-Whitney U test comparing these subgroups suggested that an abnormal DST 
was associated with SDAE in major depression patients without melancholia (p < 
0.057, one-tailed). 
Our third hypothesis was that in patients categorized by diagnostic subtype and 
DST result the following rank order would be seen with respect to SDAE: subgroup 1 
(melancholia and abnormal DST) > subgroup II (either melancholia or abnormal 
DST) > subgroup Ill (neither melancholia nor abnormal DST). Our data suggest a 
tendency for subgroups I and II to be associated with a higher rated sleep deprivation 
response than subgroup Ill, while subgroups I and II did not differ from each other 
(Table 4). Thus patients with a diagnosis of melancholia and an abnormal DST and 
patients with either a diagnosis of melancholia or an abnormal DST tended to exhibit 
a greater antidepressant effect than patients who had neither melancholia nor an 
abnormal DST. 
Table 4. Comparisons between sub- 
groups I, II, and Ill on sleep deprivation 
response ratings and results of Mann- 
Whitney U tests (one-tailed) for each 
comoarison 
Comparison P 
I vs. II < 0.27 
II vs. III < 0.03 
I vs. III < 0.07 
I = both melancholia and abnormal DST result jn = 21; 
II = either melancholia or abnormal DST result (n = 41; 
Ill = neither melancholia nor abnormal DST result In = 41. 
Discussion 
These data suggest that an antidepressant response to sleep deprivation is associated 
with an early escape from dexamethasone suppression in patients with a DSM-III 
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diagnosis of major depressive episode. Two patients in our sample worsened (response 
rating < 2) as a result of sleep deprivation. Both of these patients were DST suppres- 
sors. Fifty percent (5 of 10) of patients were rated as having at least moderate 
improvement (response rating > 4). Four of these five (80%) were DST nonsuppres- 
sors. 
These findings are consistent with those of Coryell and Nasrallah (1982). Since these 
investigators did not subcategorize their major depression patients (in terms of 
presence or absence of melancholia), their data do not lend themselves to sorting out 
the relative value of DST result and diagnostic subtype for predicting SDAE. By 
categorizing our sample both in terms of DST result and depressive subtype, we were 
able, in a preliminary way, to look at the relative predictive value of these variables. 
Our data support hypothesis 2 and certain aspects of hypothesis 3. DST results in 
patients who meet criteria for major depression without melancholia have predictive 
value with respect to SDAE. On the other hand, patients with a clinical diagnosis of 
melancholia and an abnormal DST did not have a greater SDAE than patients having 
either but not both factors. Both subgroups (I and II) did, however, respond more 
favorably to sleep deprivation than patients who neither were melancholic nor had an 
abnormal DST. One hypothesis suggested by these findings is that patients who do not 
meet clinical criteria for melancholia but have an abnormal DST may be “biologically 
equivalent” (with respect to SDAE) to patients who meet clinical criteria for melan- 
cholia but have a normal DST. 
Consistent with previous studies, neither age nor sex differentiated sleep depriva- 
tion responders from nonresponders. Interestingly, the type of sleep deprivation 
(therapy vs. other) did not discriminate responders from nonresponders. Patients who 
were sleep-deprived for EEG slept up to 30 minutes during their EEG (between 8 a.m. 
and 10 a.m.). There is some evidence to suggest that napping during sleep deprivation 
adversely affects outcome (King, 1977). Two of our “EEG” patients, however, had a 
moderate response while the third had slightly less than a moderate response (3.75). It 
is conceivable that these patients might have responded even more favorably had they 
not slept. It is also possible that napping which occurs outside the “critical period” 
(King, 1977) may not adversely affect results of deprivation. The results of one study 
which found partial sleep deprivation to be as effective as total sleep deprivation 
support this hypothesis (Schilgen and Tolle, 1980). Further work is clearly needed to 
determine under what circumstances napping interferes with the SDAE. 
Since nine of our patients were on medication at the time of sleep deprivaton, the 
possibility that our findings (of an association between DST nonsuppression and an 
SDAE) could have resulted from drug effects or drug-deprivation interactions must be 
considered. 
Though patients were on medication when sleep-deprived, they were all moderately 
to severely depressed on the day preceding deprivation. The improvement which 
occurred was transient, lasting 1 day, except for one patient who remained euphoric 
for 2 days after deprivation. The transience of response, the suddenness of onset, and 
the temporal relationship to sleep deprivation closely resemble the description of the 
sleep-deprivation response in drug-free depressed patients. These observations sug- 
gest that responses were not due solely to drug effect. Improvement could have been 
due, however, to sleep deprivation or an interaction between sleep deprivation and 
medication. 
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The fact that all five patients who exhibited less than a moderate response to sleep 
deprivation (response rating < 4) were on antidepressant medication at the time of 
deprivation is consistent with the hypothesis that the transient improvement was a 
function of sleep deprivation per se. However, because we did not control for serum 
tricyclic levels or percent of platelet monoamine oxidase inhibition, the possibility that 
our results may have been due to an interaction between drug therapy and sleep 
deprivation cannot be ruled out (i.e., that responders had adequate serum tricyclic 
levels or adequate percent MAO inhibition whereas nonresponders did not). 
Studies which control for serum drug levels or which use sleep deprivation in drug- 
free patients are necessary to characterize further the relationship between DST result 
and response to sleep deprivation. 
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